Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kuo

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Academic Medicine : Journal of the Association of American Medical Colleges|June 4, 2008
Learning to take steps forwardScott Kuo
Radiology Case Reports|June 16, 2016
Non-Traumatic Fracture of an Osteochondroma Mimicking Malignant Degeneration in an Adult with Hereditary Multiple ExostosesMatthew M Robbins, Scott Kuo, Robert Epstein
The European Respiratory Journal|February 17, 2018
DNA methylation modules in airway smooth muscle are associated with asthma severityMark M Perry, Paul Lavender, Chih-Hsi Scott Kuo, et al.
Cancers|February 15, 2022
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung AdenocarcinomaChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.
BMC Cancer|July 28, 2021
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort studyChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.
Frontiers in Medicine|May 13, 2022
Interaction Between CD34<sup>+</sup> Fibrocytes and Airway Smooth Muscle Promotes IL-8 Production and Akt/PRAS40/mTOR Signaling in AsthmaTing-Yu Lin, Po-Jui Chang, Chun-Yu Lo, et al.
Cancers|February 25, 2022
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKIJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Thoracic Cancer|December 16, 2022
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancerJohn Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, et al.
Aging|January 9, 2024
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective studyLing-Jen Hung, Ping-Chih Hsu, Cheng-Ta Yang, et al.
Thoracic Cancer|May 28, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patientsJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Academic Medicine : Journal of the Association of American Medical Colleges|June 4, 2008
Learning to take steps forwardScott Kuo
Radiology Case Reports|June 16, 2016
Non-Traumatic Fracture of an Osteochondroma Mimicking Malignant Degeneration in an Adult with Hereditary Multiple ExostosesMatthew M Robbins, Scott Kuo, Robert Epstein
The European Respiratory Journal|February 17, 2018
DNA methylation modules in airway smooth muscle are associated with asthma severityMark M Perry, Paul Lavender, Chih-Hsi Scott Kuo, et al.
Cancers|February 15, 2022
Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung AdenocarcinomaChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.
BMC Cancer|July 28, 2021
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort studyChiao-En Wu, Ching-Fu Chang, Chen-Yang Huang, et al.
Frontiers in Medicine|May 13, 2022
Interaction Between CD34<sup>+</sup> Fibrocytes and Airway Smooth Muscle Promotes IL-8 Production and Akt/PRAS40/mTOR Signaling in AsthmaTing-Yu Lin, Po-Jui Chang, Chun-Yu Lo, et al.
Cancers|February 25, 2022
Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKIJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Thoracic Cancer|December 16, 2022
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancerJohn Wen-Cheng Chang, Ching-Fu Chang, Chen-Yang Huang, et al.
Aging|January 9, 2024
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective studyLing-Jen Hung, Ping-Chih Hsu, Cheng-Ta Yang, et al.
Thoracic Cancer|May 28, 2022
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patientsJohn Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, et al.
Pageof 4